2nd World Congress on

Heart and Cardiovascular Diseases

Event Date

May 13-15, 2024


Paris, France


– Previous Conference Performers / Professionals From Around The Globe

Aikaterini Ziaka

Physio4you, Greece

Elizabeth Mahon

Liverpool John Moores University, United Kingdom

Yue Feng

University in Tromso, Norway

Frederick H Silver

Rutgers, USA

Michael Fossel

Michigan State University , USA

Carlos A Hernandez Gutierrez

                                                                                                                   Instituto Tecnológico, Mexico

Ken Ware

NeuroPhysics Therapy Institute and Research Centre, Australia

Jorge Arturo Hernandez 


Nkechi M Enwerem, 

Harvard University,USA

Robert Buenker

University of Wuppertal, United States

Sandra Velez-Candelario

Family Organizational Psychology LLC, USA

Xu chen


Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!


A huge thanks to all our amazing partners. We couldn’t have a conference without you!

About Conference

Heart Congress 2024 extends a warm invitation to all individuals intrigued by the intricate functionalities and rhythms of the heart to attend the “2nd World Congress on Heart and Cardiovascular Diseases,” taking place from May 13-15, 2024. Originally slated for Paris, France, this event will now be held as a physical gathering.

Heart Congress 2024 will bring together eminent professors, scientists, researchers, students and cardiologists to delve into topics such as methodologies for heart disease remediation, electrocardiography, heart failure, pediatric cardiology, and associated health disorders. The conference aims to provide invaluable insights into the challenges impacting the diagnosis, prognosis, and treatment of cardiovascular diseases.

Theme : Cardiovascular Health Equity: Bridging Gaps, Building Bridges

Key Highlights of Euro Heart Congress 2024 in Paris, France:

Three days of robust scientific exchange

Over 200 abstracts submitted

More than 30 scientific sessions planned

Participation of over 80 international expert faculty members

Attendance by over 100 healthcare professionals

This international conference offers a unique opportunity for clinicians, scientists, doctors, and researchers worldwide to come together, exchange scientific ideas, and stay abreast of the latest advances in cardiology and healthcare.

Why Attend?

Attendees can expect to engage with a diverse global community focused on exploring recent developments and solutions in cardiology and healthcare. Renowned keynote and plenary speakers, alongside the latest advancements in the field, signify the significance of this conference. Participation in this event fosters networking opportunities, collaboration, and knowledge-sharing among experts, researchers, and academicians.

Conference Opportunities:

For Researchers and Faculty Members:

Speaker Presentations

Poster Displays

Symposium Hosting (Team of 4-5 members)

Workshop Organization

For Universities, Associations & Societies:

Book Launch Events

Networking Opportunities

Audience Participation

For Product Manufacturers:

Exhibitr and Vendor Booths

Sponsorship Opportunities

Product Launches

Workshop Organization

Scientific Partnering

Marketing and Networking with Clients

Session and Tracks 

Track 1: Heart Disease & Failure

Heart disease encompasses disorders affecting the heart, including blood vessel diseases like coronary artery disease, heart rhythm problems (arrhythmias), and congenital heart defects. Heart failure occurs when the heart can’t pump enough blood to meet the body’s needs, but it doesn’t mean the heart has stopped working. Conditions include coronary artery disease, congenital heart defects, and cardiomyopathy.


Atrial Fibrillation

Atrial Myxoma

Unstable Angina


Transient Ischemic Attack



Cardiac Stroke

Track 2: Cardiac and Cardiovascular Research

This track focuses on raising awareness about heart disease risk factors and providing comprehensive cardiovascular services. It emphasizes prevention, detection, management, and treatment of cardiovascular diseases through postgraduate education and scientific work.

Cardiac Electrophysiology

Peripheral Arterial Disease

3D Cardiac Cell Modeling

Genetic Basis for Inherited Cardiovascular Disease


Track 3: Diabetes, Obesity & Stroke

Obesity increases the risk of heart disease and stroke, often due to lifestyle choices like lack of exercise and poor diet. Diabetes and pre-diabetes also elevate cardiovascular risk. This track emphasizes managing blood glucose, hypertension, and blood cholesterol to lower the risk of heart disease and stroke.

Diabetes Mellitus and Stroke

Abdominal Obesity

Vascular Dementia

Abnormal Cholesterol and High Triglycerides

Hemorrhagic Strokes (Bleeds)

Track 4: Pediatric Cardiology

This track deals with diagnosing and managing congenital heart defects and other cardiac conditions in infants, children, and adolescents. It addresses inflammatory heart diseases, such as myocarditis, and conditions like Kawasaki disease.

Cardiac Malformation

Congenital Abnormalities

Hypplastic Left Heart Syndromes

Auditory Stimulation Therapy



Track 5: Cardiovascular Disease

Covering a range of heart and blood vessel disorders, including coronary artery diseases, stroke, heart failure, and congenital heart defects. It highlights the importance of managing risk factors like hypertension and obesity.


Valvular Heart Diseases

Coronary Artery Diseases

Rheumatic Heart Diseases

Congenital Heart Defect

Venous Thrombosis

Track 6: Women’s Cardiology

Focuses on cardiovascular health in women, addressing specific issues like pregnancy-related disorders and the persistence of weight gain after pregnancy. It aims to bridge the gap in sex-specific data collection and its translation into clinical practice.

Pregnancy-related disorders and CVD risk association

Persistence of weight gain after pregnancy

Radiation and chemotherapy for breast cancer

ASA in women with diabetes mellitus

Ischemic heart disease in women

Acute coronary syndromes in women

Track 7: Nuclear Cardiology

Utilizes nuclear imaging techniques for non-invasive cardiovascular disease evaluation. It involves injecting radiotracers into the bloodstream to create images of the heart, aiding in diagnosis and treatment planning.

Modern practices in cardiovascular therapy


Percutaneous Coronary Intervention (PCI)

Heart Transplant

Application of cardiac progenitor cells

Track 8: Angiography & Intervention

Focuses on visualizing blood vessels through angiography and catheter-based treatments for structural heart diseases. It emphasizes minimally invasive approaches to avoid scarring and long recovery periods.


Percutaneous valve replacement

Neuro-Vascular Angiography



Track 9: Molecular Cardiology

Studies genetic heart disorders and aims to reduce human disease through integrating basic science research and clinical cardiology. It explores the link between genetics, environmental factors, and cardiovascular diseases.

Gene Analysis in the Diseased Heart

Investigate the stem cell niche in tissue regeneration.

Medical genetics

Integrins and chemokine receptors in heart physiology & cardiovascular disease

Track 10: Cardio-Oncology

Addresses heart conditions in cancer patients, focusing on potential risks associated with cancer treatment. It involves close monitoring of heart health during treatment and the management of chemotherapy-related cardiac dysfunctions.

Chemotherapy-related cardiac dysfunctions

Platinum-based chemotherapy agents

Cardio-oncology programs

Novel targeted therapies

Radiation-Induced Heart Disease

Track 11: Cardiologists

Specializes in heart and blood vessel disorders, providing diagnosis, treatment, and prevention services. It encompasses various specialties like general clinical cardiology, pediatric cardiology, and preventive cardiology.

General clinical cardiologists

Pediatric cardiologists

Cardiovascular Anesthesiology

Cardiovascular Pathology Research

Preventive cardiologists

Track 12: Vascular Biology

Studies vascular function, structure, growth, and development to improve blood flow and organ perfusion. It focuses on identifying new therapeutic targets and developing novel treatment approaches.

Angiogenic gene therapy

Oxidative stress and vascular biology

Vascular Surgery

Vascular medicine

Vascular Imaging and Diagnostic Testing

Molecular Biophysics and Structural Biology

Stem Cell Biology

Track 13: Hypertension

Addresses persistently elevated blood pressure and its implications, including risks of heart attack, stroke, and other complications. It emphasizes screening, management, and treatment of hypertension.

Pulmonary hypertension

Perioperative management in hypertension

Erectile dysfunction

Systolic/Diastolic malfunction

Indications and contraindications for antihypertensive drugs

Hypertension in acute stroke

Track 14: Cardiac Nursing

Specializes in caring for patients with cardiovascular diseases, providing postoperative care, stress test evaluations, and cardiac monitoring. It encompasses various environments like coronary care units, intensive care units, and cardiac rehabilitation centers.

Stress test evaluations

Hemodynamic Monitoring

Monitoring cardiac and vascular readings

Intensive hemodialysis

Carig for Heart Transplant Patients

Track 15: Heart Regeneration

Focuses on repairing or replacing damaged heart tissue using techniques like stem cell therapy and tissue engineering. It aims to restore heart function by harnessing the body’s natural regenerative capacity.

Transdifferentiation During Heart Regeneration

Cardiac Remodeling

Cardiac-Derived Stem Cells

Tissue Engineering-Concepts for Generation of Cardiac Tissue

Biomimetic Heart Valve Replacement

Track 16: Cardiac Pharmacology

Deals with medication for cardiac diseases, including categories like cardiac glycosides, anti-coagulants, and anti-hypertensive agents. It emphasizes the development of new drugs and managing drug-induced cardiac toxicity.

Drug-Induced Cardiac Toxicity

Novel Anti-Inflammatory Therapies for Atherosclerosis

Development of Novel Anti-Ischemic Agents

Beta Blockers Blocking

Cardiac Glycoside

Track 17: Cardiology – Future Medicine

Explores advancements and innovations in cardiology, including personalized medicine, novel treatment approaches, and the role of technology. It aims to improve clinical practice and patient outcomes.

Development of pacemaking and Cardiac Conduction System Lineages

Rol of platelets and antiplatelet therapy in cardiovascular disease

Molecular Targets of Antihypertensive Drug Therapy

Real-world Evidence and Outcomes Research

‘Personalized Medicine’ In Cardiology

Track 18: Case Reports on Cardiology

Highlights case studies to advance treatment strategies and improve understanding of cardiac disorders. It emphasizes networking and knowledge sharing among professionals and academicians.

Aortic Diseases

Infective Endocarditis

Disorders due to Coronary Circulation

Myocardium and Pericardium

How to Counter Coronary Artery Disease

Track 19: Heart Diagnosis

Focuses on various diagnostic methods for heart diseases, including imaging techniques and cardiac surgeries. It emphasizes the importance of early detection and medical care for managing heart conditions.

Electrocardiogram & Echocardiography

Holter Monitoring

Cardiac Computerized Tomography (CT) scan

Cardiac Magnetic Resonance Imaging (MRI)

Chest X-ray

Track 20: Heart Devices

Involves electronic devices for assisting cardiac circulation, such as pacemakers, defibrillators, and biosensors. It explores advancements in wireless cardiac monitoring and individualized medicine.

Implantable Cardioverter-Defibrillator (ICD)

Cardiac Resynchronization Therapy (CRT)

Left Ventricular Assist Device (LVAD)

The Heart Ware’s Ventricular Assist System

The Levacor Heart Pump

Track 21: Cardiac Surgery

Addresses surgical interventions for heart and blood vessel disorders, including coronary artery bypass grafting and valve replacement. It emphasizes minimally invasive approaches and heart transplantation.

Minimally Invasive Coronary Artery Bypass Surgery

Valve-Sparing Aortic Root Replacement

Open-heart surgery

Transmyocardial Laser Revascularization

Off-Pump Heart Surgery

Market Analysis

The primary objective of the 2nd World Congress on Heart and Cardiovascular Diseases is to ensure the provision of clinically appropriate and cost-effective care for individuals suffering from heart disease. This initiative is prompted predominantly by conditions such as ischemic heart disease, stroke, dyslipidemia, thrombosis, atherosclerosis, coronary artery diseases, peripheral artery disease, hypertension, and others. The leading causes of these disorders include unhealthy dietary habits, obesity, smoking, high cholesterol, sedentary lifestyle, excessive alcohol consumption, and poor overall lifestyle choices. With cardiovascular diseases responsible for approximately 15 million deaths globally each year, and constituting a significant cause of mortality in about 50% of adults, there is an urgent need for a dedicated platform for the advancement, implementation, and dissemination of knowledge concerning Cardiovascular Medicine and its associated fields through events like National/International symposiums, Conferences, and Workshops.


Aetiology, Clinical Characteristics, and Therapy:

Heart failure’s etiology includes hypertension (45%), cardiomyopathies (28%), rheumatic heart disease (12%), ischemic heart disease (9%), and other factors such as probable tuberculosis or HIV-related cardiomyopathies, endomyocardial fibrosis, and obstructive lung disease (6%). Among cardiomyopathies, idiopathic dilated cardiomyopathy was the most prevalent (81%), followed by postpartum cardiomyopathy (15%), while hypertrophic and restrictive cardiomyopathies were less common (5%). Rheumatic mitral disease with regurgitation was the most prevalent valvular lesion (81%), followed by mitral stenosis (15%) and aortic regurgitation (3%).


Importance and Scope:

The World Cardiology Meeting serves as an ideal platform for scientists, cardiologists, oncologists, electrophysiologists, surgeons, nurses, research scholars, and students to exchange knowledge in the field of Cardiology and Cardiac Surgery. This international event aims to explore alternatives to invasive imaging techniques for diagnosing heart diseases and heart failure in both adults and children.


Cardiology Market Growth:

North America dominates the heart diagnostics market, accounting for approximately 47% of revenue share in 2024, followed by Europe (38%) and Asia (15%).

Statistics of Physicians, Researchers, and Academicians in Cardiology Research:

Key contributors in the field of Cardiology include Directors, Heads, Deans, Professors, Scientists, Researchers, Doctors, Students, and Writers in the Pediatric Cardiology Department. Additionally, individuals associated with related companies, associations, laboratories, and other organizations play a significant role in advancing Cardiology research.

Therapeutic Approaches:

The primary goal of heart failure therapy is to impede disease progression through pharmacological and device-based interventions. Efforts are directed towards developing device-based therapies that enhance cardiac reserve and optimize pump function to meet metabolic demands. Timely identification of subtle pathophysiologic changes associated with heart failure could potentially lead to preventive measures, highlighting the potential role of device-based methods in identifying such changes.

– Quick Contact –